{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T22:48:56Z","timestamp":1754261336469,"version":"3.37.3"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf - Case Rep"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s40800-017-0070-z","type":"journal-article","created":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T03:39:24Z","timestamp":1516160364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Desvenlafaxine-Induced Interstitial Pneumonitis: A Case Report"],"prefix":"10.1007","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4617-5810","authenticated-orcid":false,"given":"Arjan","family":"Flora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Pipoly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,17]]},"reference":[{"issue":"10","key":"70_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1157\/13126838","volume":"44","author":"L Border\u00edas Clau","year":"2008","unstructured":"Border\u00edas Clau L, Marigil G\u00f3mez MA, Val Ad\u00e1n P, Marc\u00e9n Letosa M, Biescas L\u00f3pez R, Garrapiz L\u00f3pez FJ. Hypersensitivity pneumonitis due to venlafaxine. Arch Bronconeumol. 2008;44(10):571\u20133.","journal-title":"Arch Bronconeumol"},{"key":"70_CR2","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1164\/rccm.200207-739CR","volume":"167","author":"M Drent","year":"2003","unstructured":"Drent M, Singh S, Gorgeis A, et al. Drug-induced pneumonitis and heart failure simultaneously associated with venlafaxine. Am J Respir Crit Care Med. 2003;167:958\u201361.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"70_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1590\/S1806-37132014000300015","volume":"40","author":"PG Ferreira","year":"2014","unstructured":"Ferreira PG, Costa S, Dias N, et al. Simultaneous interstitial pneumonitis and cardiomyopathy induced by venlafaxine. J Bras Pneumol. 2014;40(3):313\u20138.","journal-title":"J Bras Pneumol."},{"key":"70_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4046\/trd.2014.77.2.81","volume":"77","author":"S Oh","year":"2014","unstructured":"Oh S, Cha SI, Kim H, et al. A case of venlafaxine-induced interstitial lung disease. Tuberc Respir Dis. 2014;77:81\u20134.","journal-title":"Tuberc Respir Dis"},{"issue":"4","key":"70_CR5","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1592\/phco.25.4.626.61029","volume":"25","author":"RC Turner","year":"2005","unstructured":"Turner RC, Nelson JE, Roberts BT, et al. Venlafaxine-associated interstitial pneumonitis. Pharmacotherapy. 2005;25(4):626\u20139.","journal-title":"Pharmacotherapy."},{"issue":"1","key":"70_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1176\/appi.psy.49.1.84","volume":"49","author":"M Vazquez","year":"2008","unstructured":"Vazquez M, Quevedo B. Pneumonitis related to venlafaxine. Psychomatics. 2008;49(1):84\u20135.","journal-title":"Psychomatics."},{"key":"70_CR7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.phrs.2017.04.010","volume":"120","author":"A Deidda","year":"2017","unstructured":"Deidda A, Pisanu C, Micheletto L, Bocchetta A, Del Zompo M, Stochino ME. Interstitial lung disease induced by fluoxetine: systematic review of literature and analysis of VigiAccess, EudraVigilance and a national pharmacovigilance database. Pharmacol Res. 2017;120:294\u2013301.","journal-title":"Pharmacol Res"},{"issue":"2","key":"70_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239\u201345.","journal-title":"Clin Pharmacol Ther"},{"key":"70_CR9","volume-title":"Foye\u2019s principles of medicinal chemistry","author":"TL Lemke","year":"2012","unstructured":"Lemke TL, Williams DA. Foye\u2019s principles of medicinal chemistry. Philadelphia: Lippincott Williams & Wilkins; 2012."}],"container-title":["Drug Safety - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40800-017-0070-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40800-017-0070-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40800-017-0070-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T19:23:54Z","timestamp":1547666634000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40800-017-0070-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,17]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["70"],"URL":"https:\/\/doi.org\/10.1007\/s40800-017-0070-z","relation":{},"ISSN":["2199-1162","2198-977X"],"issn-type":[{"type":"print","value":"2199-1162"},{"type":"electronic","value":"2198-977X"}],"subject":[],"published":{"date-parts":[[2018,1,17]]},"assertion":[{"value":"17 January 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Arjan Flora, MD has no conflicts of interest that are directly relevant to the content of this study. Daniel Pipoly, MD has no conflicts of interest that are directly relevant to the content of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from the patient for publication of this case report. A copy of the written consent may be requested for review from the corresponding author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"5"}}